AAAAAA

   
Results: 1-12 |
Results: 12

Authors: DONNER B RABER M ZENZ M STRUMPF M DERTWINKEL R
Citation: B. Donner et al., EXPERIENCES WITH THE PRESCRIPTION OF OPIOIDS - A PATIENT QUESTIONNAIRE, Journal of pain and symptom management, 15(4), 1998, pp. 231-234

Authors: DONNER B ZENZ M STRUMPF M RABER M
Citation: B. Donner et al., LONG-TERM TREATMENT OF CANCER PAIN WITH TRANSDERMAL FENTANYL, Journal of pain and symptom management, 15(3), 1998, pp. 168-175

Authors: GAJEWSKI J RONDON G MIRZA N MEHRA R DONATO M ANDERLINI P KORBLING M THERIALT R KHOURI I GIRALT S BUZDAR A UENO N PRZEPIORKA D ANDERSSON B DURRETT A SALIBA R BRUTON J RAHMAN Z IPPOLITI C HORTABAQYI G RABER M BAST R CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371

Authors: RABER M ZENZ M
Citation: M. Raber et M. Zenz, A NEW METHOD FOR THE TREATMENT OF REFRACT ORY TRIGEMINAL NEURALGIA, Anasthesiologie und Intensivmedizin, 39(3), 1998, pp. 157-159

Authors: KUDELKA AP TRESUKOSOL D EDWARDS CL FREEDMAN RS LEVENBACK C CHANTARAWIROJ P DELEON CG KIM EE MADDEN T WALLIN B HORD M VERSCHRAEGEN C RABER M KAVANAGH JJ
Citation: Ap. Kudelka et al., PHASE-II STUDY OF INTRAVENOUS TOPOTECAN AS A 5-DAY INFUSION FOR REFRACTORY EPITHELIAL OVARIAN-CARCINOMA, Journal of clinical oncology, 14(5), 1996, pp. 1552-1557

Authors: RABER M
Citation: M. Raber, DOWNSIZING OF THE NATIONS LABOR-FORCE AND A NEEDED SOCIAL-WORK RESPONSE, Administration in social work, 20(1), 1996, pp. 47

Authors: MAFFEZZINI M SIMONATO A ZANON M RABER M CARMIGNANI G
Citation: M. Maffezzini et al., UP-FRONT INTRAVESICAL CHEMOTHERAPY FOR LOW STAGE, LOW-GRADE RECURRENTBLADDER-CANCER, The Journal of urology, 155(1), 1996, pp. 91-93

Authors: MAFFEZZINI M SIMONATO A ZANON M RABER M CARMIGNANI G
Citation: M. Maffezzini et al., UP-FRONT INTRAVESICAL CHEMOTHERAPY FOR LOW STAGE, LOW-GRADE RECURRENTBLADDER-CANCER - REPLY, The Journal of urology, 155(1), 1996, pp. 93-93

Authors: FOSSELLA FV LEE JS SHIN DM CALAYAG M HUBER M PEREZSOLER R MURPHY WK LIPPMAN S BENNER S GLISSON B CHASEN M HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 645-651

Authors: MAFFEZZINI M SIMONATO A LODOLO C RABER M CARMIGNANI G
Citation: M. Maffezzini et al., SHORT SCHEDULE INTRAVESICAL MITOMYCIN PRECEDING TRANSURETHRAL RESECTION FOR RECURRENT TA-T1, G1-G2 BLADDER-CANCER, Tumori, 81(3), 1995, pp. 191-193

Authors: FOSSELLA FV LEE JS MURPHY WK LIPPMAN SM CALAYAG M PANG A CHASEN M SHIN DM GLISSON B BENNER S HUBER M PEREZSOLER R HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1238-1244

Authors: HAWKINS MJ RABER M
Citation: Mj. Hawkins et M. Raber, MENTAL-HEALTH-CARE REFORM - IMPLICATIONS FOR SOCIAL-WORK, Hospital & community psychiatry, 44(11), 1993, pp. 1045-1046
Risultati: 1-12 |